Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 176
- +28 vs. Q3 2025
- Portfolio value
- $5.28B
- +$464.1M (+9.6%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 5,005,719 | $398.7M | 7.6% | −568,119−10.2% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 461,854 | $388.4M | 7.4% | −84,474−15.5% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 4,802,199 | $379.9M | 7.2% | −1,442,252−23.1% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 681,120 | $308.8M | 5.9% | +175,315+34.7% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 1,703,304 | $241.6M | 4.6% | −59,801−3.4% | Reduced | History |
| Avidity Biosciences, Inc.05370A108 | COM | 2,630,969 | $189.8M | 3.6% | +478,107+22.2% | Added | – |
| ISRGIntuitive Surgical Inc | COM NEW | 322,028 | $182.4M | 3.5% | −26,598−7.6% | Reduced | History |
| SRRKScholar Rock Holding Corp | COM | 4,056,592 | $178.7M | 3.4% | +812,055+25.0% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 445,903 | $177.3M | 3.4% | −621−0.1% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,316,915 | $165.0M | 3.1% | −161,648−10.9% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 10,735,195 | $152.9M | 2.9% | +10,735,195 | New | History |
| BSXBoston Scientific Corp | Stock | 1,559,606 | $148.7M | 2.8% | −100,243−6.0% | Reduced | History |
| VRDNViridian Therapeutics, Inc. | COM | 4,358,527 | $135.6M | 2.6% | +4,358,527 | New | History |
| SYKStryker Corp | Stock | 360,577 | $126.7M | 2.4% | −90,519−20.1% | Reduced | History |
| NUVLNuvalent, Inc. | COM | 1,037,468 | $104.4M | 2.0% | +1,037,468 | New | History |
| KRYSKrystal Biotech, Inc. | COM | 410,323 | $101.2M | 1.9% | +409,011+31,174.6% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 3,617,669 | $98.3M | 1.9% | +60,000+1.7% | Added | History |
| IMCRImmunocore Holdings plc | ADS | 2,796,803 | $97.1M | 1.8% | 00.0% | Unchanged | History |
| EWEdwards Lifesciences Corp | Stock | 1,043,096 | $88.9M | 1.7% | +146,463+16.3% | Added | History |
| VERAVera Therapeutics, Inc. | CL A | 1,698,152 | $86.0M | 1.6% | +1,698,152 | New | History |
| MDTMedtronic plc | Stock | 766,592 | $73.6M | 1.4% | +6,731+0.9% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 8,345,364 | $70.6M | 1.3% | −2460.0% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 94,539 | $64.0M | 1.2% | +17,952+23.4% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 175,169 | $57.8M | 1.1% | +5,112+3.0% | Added | History |
| DXCMDexcom Inc | COM | 847,405 | $56.2M | 1.1% | +61,287+7.8% | Added | History |
| PODDInsulet Corp | Stock | 186,699 | $53.1M | 1.0% | −25,306−11.9% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 265,662 | $51.6M | 1.0% | −31,232−10.5% | Reduced | History |
| JBIOJade Biosciences, Inc. | COM NEW | 3,341,103 | $51.6M | 1.0% | +3,341,103 | New | History |
| DHRDanaher Corp | Stock | 194,633 | $44.6M | 0.8% | +30,757+18.8% | Added | History |
| PENPenumbra Inc | COM | 135,395 | $42.1M | 0.8% | −11,500−7.8% | Reduced | History |
| RMDResmed Inc | COM | 161,214 | $38.8M | 0.7% | −3,620−2.2% | Reduced | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,528,518 | $37.9M | 0.7% | −1,247,479−44.9% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 65,077 | $37.7M | 0.7% | −41,108−38.7% | Reduced | History |
| MAZEMaze Therapeutics, Inc. | COM | 887,708 | $36.8M | 0.7% | +887,708 | New | History |
| LLYEli Lilly & Co | Stock | 34,003 | $36.5M | 0.7% | −6,511−16.1% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 424,514 | $34.8M | 0.7% | −38,549−8.3% | Reduced | History |
| TNGXTango Therapeutics, Inc. | COM | 3,927,670 | $34.8M | 0.7% | +3,927,670 | New | History |
| ABBVAbbVie Inc. | Stock | 134,859 | $30.8M | 0.6% | −36,011−21.1% | Reduced | History |
| CICigna Group | Stock | 110,013 | $30.3M | 0.6% | −12,473−10.2% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 261,935 | $29.6M | 0.6% | +206,009+368.4% | Added | History |
| JNJJohnson & Johnson | Stock | 126,800 | $26.2M | 0.5% | +51,993+69.5% | Added | History |
| ANNXAnnexon, Inc. | COM | 5,157,290 | $25.9M | 0.5% | 00.0% | Unchanged | History |
| STESTERIS plc | SHS USD | 101,705 | $25.8M | 0.5% | −16,407−13.9% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 1,490,518 | $25.3M | 0.5% | −2,603,940−63.6% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 69,645 | $24.4M | 0.5% | −35,326−33.7% | Reduced | History |
| COOCooper Companies, Inc. | COM | 291,959 | $23.9M | 0.5% | −306−0.1% | Reduced | History |
| GMEDGlobus Medical Inc | Stock | 262,683 | $22.9M | 0.4% | −64,184−19.6% | Reduced | History |
| ALGNAlign Technology Inc | COM | 141,474 | $22.1M | 0.4% | −3,202−2.2% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 238,680 | $21.5M | 0.4% | −6,522−2.7% | Reduced | History |
| MCKMcKesson Corp | Stock | 25,098 | $20.6M | 0.4% | −12,859−33.9% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 43,906 | $20.5M | 0.4% | −21,701−33.1% | Reduced | History |
| HUMHumana Inc | Stock | 73,081 | $18.7M | 0.4% | −3,229−4.2% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 80,529 | $18.0M | 0.3% | −16,977−17.4% | Reduced | History |
| PRCTPROCEPT BioRobotics Corp | COM | 515,430 | $16.2M | 0.3% | +52,026+11.2% | Added | History |
| NTRANatera, Inc. | COM | 56,036 | $12.8M | 0.2% | −35,782−39.0% | Reduced | History |
| MASIMasimo Corp | COM | 97,285 | $12.7M | 0.2% | +317+0.3% | Added | History |
| TMDXTransMedics Group, Inc. | COM | 97,885 | $11.9M | 0.2% | −19,083−16.3% | Reduced | History |
| CNCCentene Corp | Stock | 273,674 | $11.3M | 0.2% | −8,275−2.9% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 13,928 | $10.8M | 0.2% | −1,129−7.5% | Reduced | History |
| PRVAPrivia Health Group, Inc. | COM | 448,163 | $10.6M | 0.2% | −218,014−32.7% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 327,863 | $10.2M | 0.2% | −96,193−22.7% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 145,167 | $10.1M | 0.2% | −170,690−54.0% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 92,117 | $9.70M | 0.2% | +57,378+165.2% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 41,267 | $9.30M | 0.2% | −11,631−22.0% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 100,761 | $9.29M | 0.2% | +42,113+71.8% | Added | History |
| CVSCVS Health Corp | Stock | 109,058 | $8.65M | 0.2% | +57,859+113.0% | Added | History |
| CDNACareDx, Inc. | COM | 431,070 | $8.12M | 0.2% | −141,886−24.8% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 46,626 | $8.09M | 0.2% | −44,359−48.8% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 40,239 | $8.00M | 0.2% | −133−0.3% | Reduced | History |
| WAYWaystar Holding Corp. | COM | 241,734 | $7.92M | 0.2% | +111,821+86.1% | Added | History |
| GILDGilead Sciences, Inc. | Stock | 52,752 | $6.47M | 0.1% | +2,859+5.7% | Added | History |
| AMGNAmgen Inc | Stock | 18,489 | $6.05M | 0.1% | +3,501+23.4% | Added | History |
| TXG10x Genomics, Inc. | CL A COM | 322,060 | $5.25M | 0.1% | +8,224+2.6% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 24,330 | $5.19M | 0.1% | −573−2.3% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 27,600 | $5.04M | 0.1% | −24,735−47.3% | Reduced | History |
| MDLNMedline Inc. | COM CL A | 117,720 | $4.94M | 0.1% | +117,720 | New | History |
| ADPTAdaptive Biotechnologies Corp | COM | 298,090 | $4.84M | 0.1% | +129,614+76.9% | Added | History |
| ICLRIcon PLC | COM | 24,560 | $4.48M | 0.1% | +313+1.3% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 43,755 | $4.17M | 0.1% | +9,800+28.9% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 65,008 | $3.86M | 0.1% | −36,025−35.7% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 67,082 | $3.62M | 0.1% | +19,469+40.9% | Added | History |
| BTSGBrightSpring Health Services, Inc. | COM | 92,095 | $3.45M | 0.1% | −98,429−51.7% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 278,286 | $3.27M | 0.1% | −91,912−24.8% | Reduced | History |
| AVTRAvantor, Inc. | COM | 276,266 | $3.17M | 0.1% | +172,904+167.3% | Added | History |
| PHRPhreesia, Inc. | COM | 183,213 | $3.10M | 0.1% | −129,844−41.5% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 111,510 | $3.09M | 0.1% | −2,777,778−96.1% | Reduced | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 115,755 | $3.07M | 0.1% | −12,956−10.1% | Reduced | History |
| ILMNIllumina, Inc. | COM | 22,940 | $3.01M | 0.1% | −857−3.6% | Reduced | History |
| OMDAOmada Health, Inc. | COM | 177,897 | $2.81M | 0.1% | −73,894−29.3% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 30,431 | $2.80M | 0.1% | −5,213−14.6% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 13,915 | $2.42M | <0.1% | −6,336−31.3% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 68,665 | $2.42M | <0.1% | −7,417−9.7% | Reduced | History |
| ROIVRoivant Sciences Ltd. | SHS | 108,039 | $2.34M | <0.1% | +108,039 | New | History |
| BBNXBeta Bionics, Inc. | COM | 72,285 | $2.20M | <0.1% | +8,002+12.4% | Added | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 3,100 | $2.11M | <0.1% | 00.0% | Unchanged | History |
| EHCEncompass Health Corp | COM | 19,089 | $2.03M | <0.1% | −103,869−84.5% | Reduced | History |
| UTHRUnited Therapeutics Corp | COM | 3,895 | $1.90M | <0.1% | +1,255+47.5% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 24,111 | $1.84M | <0.1% | +3,755+18.4% | Added | History |
| BKDBrookdale Senior Living Inc. | COM | 167,444 | $1.81M | <0.1% | +62,779+60.0% | Added | History |
| SIBNSI-BONE, Inc. | COM | 90,331 | $1.78M | <0.1% | −208,526−69.8% | Reduced | History |
Sold out since Q3 2025 (9)
Positions held at the end of Q3 2025 that are gone from this filing.
| Security | Class | Shares in Q3 2025 | Value in Q3 2025 | % of portfolio in Q3 2025 | History |
|---|---|---|---|---|---|
| AGIOAgios Pharmaceuticals, Inc. | COM | 3,714,736 | $149.1M | 3.1% | History |
| AKROAkero Therapeutics, Inc. | COM | 2,389,314 | $113.4M | 2.4% | History |
| BHVNBiohaven Ltd. | COM | 2,802,853 | $42.1M | 0.9% | History |
| HOLXHologic Inc | COM | 247,886 | $16.7M | 0.3% | History |
| MGNXMacrogenics Inc | COM | 9,919,992 | $16.7M | 0.3% | History |
| BAXBaxter International Inc | Stock | 68,084 | $1.55M | <0.1% | History |
| BIDUBaidu, Inc. | ADR | 2,000 | $263.5K | <0.1% | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 35,052 | $251.3K | <0.1% | History |
| MRUSMerus N.V. | COM | 825 | $77.7K | <0.1% | History |